DOI QR코드

DOI QR Code

α-Isocubebene modulates vascular tone by inhibiting myosin light chain phosphorylation in murine thoracic aorta

  • Ye, Byeong Hyeok (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Kim, Eun Jung (Gene & Cell Therapy Research Center for Vessel-associated Diseases, Pusan National University) ;
  • Baek, Seung Eun (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Choi, Young Whan (College of Natural Resources & Life Sciences, Pusan National University) ;
  • Park, So Youn (Gene & Cell Therapy Research Center for Vessel-associated Diseases, Pusan National University) ;
  • Kim, Chi Dae (Department of Pharmacology, School of Medicine, Pusan National University)
  • Received : 2018.03.13
  • Accepted : 2018.04.24
  • Published : 2018.07.01

Abstract

${\alpha}$-Iso-cubebene (ICB) is a dibenzocyclooctadiene lignin contained in Schisandra chinensis (SC), a well-known medicinal herb that ameliorates cardiovascular symptoms, but the mechanism responsible for this activity has not been determined. To determine the role played by ICB on the regulation of vascular tone, we investigated the inhibitory effects of ICB on vascular contractile responses by adrenergic ${\alpha}$-receptor agonists. In addition, we investigated the role on myosin light chain (MLC) phosphorylation and cytosolic calcium concentration in vascular smooth muscle cells (VSMC). In aortic rings isolated from C57BL/6J mice, ICB significantly attenuated the contraction induced by phenylephrine (PE) and norepinephrine (NE), whereas ICB had no effects on KCl (60 mM)-induced contraction. In vasculatures precontracted with PE, ICB caused marked relaxation of aortic rings with or without endothelium, suggesting a direct effect on VSMC. In cultured rat VSMC, PE or NE increased MLC phosphorylation and increased cytosolic calcium levels. Both of these effects were significantly suppressed by ICB. In conclusion, our results showed that ICB regulated vascular tone by inhibiting MLC phosphorylation and calcium flux into VSMC, and suggest that ICB has anti-hypertensive properties and therapeutic potential for cardiovascular disorders related to vascular hypertension.

Keywords

References

  1. Flack JM, Oparil S, Pratt JH, Roniker B, Garthwaite S, Kleiman JH, Yang Y, Krause SL, Workman D, Saunders E. Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients. J Am Coll Cardiol. 2003;41:1148-1155. https://doi.org/10.1016/S0735-1097(03)00054-8
  2. Ohanian J, Ohanian V. Lipid second messenger regulation: the role of diacylglycerol kinases and their relevance to hypertension. J Hum Hypertens. 2001;15:93-98. https://doi.org/10.1038/sj.jhh.1001139
  3. Touyz RM, He G, Wu XH, Park JB, Mabrouk ME, Schiffrin EL. Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Hypertension. 2001;38:56-64. https://doi.org/10.1161/01.HYP.38.1.56
  4. Staiculescu MC, Galinanes EL, Zhao G, Ulloa U, Jin M, Beig MI, Meininger GA, Martinez-Lemus LA. Prolonged vasoconstriction of resistance arteries involves vascular smooth muscle actin polymerization leading to inward remodelling. Cardiovasc Res. 2013;98:428-436. https://doi.org/10.1093/cvr/cvt034
  5. Horowitz A, Menice CB, Laporte R, Morgan KG. Mechanisms of smooth muscle contraction. Physiol Rev. 1996;76:967-1003. https://doi.org/10.1152/physrev.1996.76.4.967
  6. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature. 1994;372:231-236. https://doi.org/10.1038/372231a0
  7. Kim JI. High fat diet confers vascular hyper-contractility against angiotensin II through upregulation of MLCK and CPI-17. Korean J Physiol Pharmacol. 2017;21:99-106. https://doi.org/10.4196/kjpp.2017.21.1.99
  8. Somlyo AP, Somlyo AV. $Ca^{2+}$ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 2003;83:1325-1358. https://doi.org/10.1152/physrev.00023.2003
  9. Webb RC. Smooth muscle contraction and relaxation. Adv Physiol Educ. 2003;27:201-206. https://doi.org/10.1152/advan.00025.2003
  10. Christ G, Wingard C. Calcium sensitization as a pharmacological target in vascular smooth-muscle regulation. Curr Opin Investig Drugs. 2005;6:920-933.
  11. Kitazawa T, Gaylinn BD, Denney GH, Somlyo AP. G-proteinmediated $Ca^{2+}$ sensitization of smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem. 1991;266:1708-1715.
  12. Gong MC, Cohen P, Kitazawa T, Ikebe M, Masuo M, Somlyo AP, Somlyo AV. Myosin light chain phosphatase activities and the effects of phosphatase inhibitors in tonic and phasic smooth muscle. J Biol Chem. 1992;267:14662-14668.
  13. Mu Y, Zhang J, Zhang S, Zhou HH, Toma D, Ren S, Huang L, Yaramus M, Baum A, Venkataramanan R, Xie W. Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J Pharmacol Exp Ther. 2006;316:1369-1377.
  14. Huang SX, Li RT, Liu JP, Lu Y, Chang Y, Lei C, Xiao WL, Yang LB, Zheng QT, Sun HD. Isolation and characterization of biogenetically related highly oxygenated nortriterpenoids from Schisandra chinensis. Org Lett. 2007;9:2079-2082. https://doi.org/10.1021/ol070510z
  15. Rhyu MR, Kim EY, Yoon BK, Lee YJ, Chen SN. Aqueous extract of Schizandra chinensis fruit causes endothelium-dependent and -independent relaxation of isolated rat thoracic aorta. Phytomedicine. 2006;13:651-657. https://doi.org/10.1016/j.phymed.2006.02.003
  16. Park JY, Shin HK, Lee YJ, Choi YW, Bae SS, Kim CD. The mechanism of vasorelaxation induced by Schisandra chinensis extract in rat thoracic aorta. J Ethnopharmacol. 2009;121:69-73. https://doi.org/10.1016/j.jep.2008.09.031
  17. Park JY, Choi YW, Yun JW, Bae JU, Seo KW, Lee SJ, Park SY, Kim CD. Gomisin J from Schisandra chinensis induces vascular relaxation via activation of endothelial nitric oxide synthase. Vascul Pharmacol. 2012;57:124-130. https://doi.org/10.1016/j.vph.2012.06.002
  18. Lee YJ, Shim JW, Lee YJ, Park YH, Lee HY, Kim SD, Choi YW, Bae YS. Identification of a novel compound that stimulates intracellular calcium increase and CXCL8 production in human neutrophils from Schisandra chinensis. Biochem Biophys Res Commun. 2009;379:928-932. https://doi.org/10.1016/j.bbrc.2008.12.174
  19. Qi H, Li L, Shuai J. Optimal microdomain crosstalk between endoplasmic reticulum and mitochondria for $Ca^{2+}$ oscillations. Sci Rep. 2015;5:7984. https://doi.org/10.1038/srep07984
  20. Turbedsky K, Pollard TD, Bresnick AR. A subset of protein kinase C phosphorylation sites on the myosin II regulatory light chain inhibits phosphorylation by myosin light chain kinase. Biochemistry. 1997;36:2063-2067. https://doi.org/10.1021/bi9624651
  21. Chen K, Li C. Recent advances in studies on traditional Chinese anti-aging material medica. J Tradit Chin Med. 1993;13:223-226.
  22. You JS, Pan TL, Hou YC. Schisandra chinensis protects against adriamycin-induced cardiotoxicity in rats. Chang Gung Med J. 2006;29:63-70.
  23. Choi YW, Takamatsu S, Khan SI, Srinivas PV, Ferreira D, Zhao J, Khan IA. Schisandrene, a dibenzocyclooctadiene lignan from Schisandra chinensis: structure-antioxidant activity relationships of dibenzocyclooctadiene lignans. J Nat Prod. 2006;69:356-359. https://doi.org/10.1021/np0503707
  24. Lu Y, Chen DF. Analysis of Schisandra chinensis and Schisandra sphenanthera. J Chromatogr A. 2009;1216:1980-1990. https://doi.org/10.1016/j.chroma.2008.09.070
  25. Park SY, Park SJ, Park NJ, Joo WH, Lee SJ, Choi YW. ${\alpha}$-Isocubebene exerts neuroprotective effects in amyloid beta stimulated microglia activation. Neurosci Lett. 2013;555:143-148. https://doi.org/10.1016/j.neulet.2013.09.053
  26. Choi YW, Kim HJ, Park SS, Chung JH, Lee HW, Oh SO, Kim BS, Kim JB, Chung HY, Yu BP, Kim CD, Yoon S. Inhibition of endothelial cell adhesion by the new anti-inflammatory agent alpha-isocubebene. Vascul Pharmacol. 2009;51:215-224. https://doi.org/10.1016/j.vph.2009.05.008
  27. Park SY, Park TG, Lee SJ, Bae YS, Ko MJ, Choi YW. ${\alpha}$-Iso-cubebenol inhibits inflammation-mediated neurotoxicity and amyloid beta 1-42 fibril-induced microglial activation. J Pharm Pharmacol. 2014;66:93-105. https://doi.org/10.1111/jphp.12160
  28. Park SY, Choi YH, Park G, Choi YW. Neuroprotective effects of ${\alpha}$-iso-cubebenol on glutamate-induced neurotoxicity. Environ Toxicol Pharmacol. 2015;40:549-556. https://doi.org/10.1016/j.etap.2015.08.008
  29. Jang MA, Lee SJ, Baek SE, Park SY, Choi YW, Kim CD. ${\alpha}$-Iso-Cubebene inhibits PDGF-induced vascular smooth muscle cell proliferation by suppressing osteopontin expression. PLoS One. 2017;12:e0170699. https://doi.org/10.1371/journal.pone.0170699
  30. Safar ME, Balkau B, Lange C, Protogerou AD, Czemichow S, Blacher J, Levy BI, Smulyan H. Hypertension and vascular dynamics in men and women with metabolic syndrome. J Am Coll Cardiol. 2013;61:12-19. https://doi.org/10.1016/j.jacc.2012.01.088
  31. Touyz RM, Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P) H oxidase-sensitive pathways. J Hypertens. 2001;19:1245-1254. https://doi.org/10.1097/00004872-200107000-00009
  32. Nishimura J, Khalil RA, van Breemen C. Agonist-induced vascular tone. Hypertension. 1989;13:835-844. https://doi.org/10.1161/01.HYP.13.6.835
  33. Sun N, Hong T, Zhang R, Yang X. The effects of verapamil SR and bisoprolol on reducing the sympathetic nervous system's activity. Hypertens Res. 2000;23:537-540. https://doi.org/10.1291/hypres.23.537
  34. Zheng C, Lo CY, Meng Z, Li Z, Zhong M, Zhang P, Lu J, Yang Z, Yan F, Zhang Y, Huang Y, Yao X. Gastrodin inhibits store-operated $Ca^{2+}$ entry and alleviates cardiac hypertrophy. Front Pharmacol. 2017;8:222. https://doi.org/10.3389/fphar.2017.00222
  35. Meisheri KD, Hwang O, van Breemen C. Evidence for two separated $Ca^{2+}$ pathways in smooth muscle plasmalemma. J Membr Biol. 1981;59:19-25. https://doi.org/10.1007/BF01870817
  36. Eto K, Ohya Y, Nakamura Y, Abe I, Fujishima M. Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle. Eur J Pharmacol. 2001;423:1-7. https://doi.org/10.1016/S0014-2999(01)01047-0
  37. Shibata K, Sakai H, Huang Q, Kamata H, Chiba Y, Misawa M, Ikebe R, Ikebe M. Rac1 regulates myosin II phosphorylation through regulation of myosin light chain phosphatase. J Cell Physiol. 2015;230:1352-1364. https://doi.org/10.1002/jcp.24878
  38. Kokubo Y, Okamura T, Watanabe M, Higashiyama A, Ono Y, Miyamoto Y, Furukawa Y, Kamide K, Kawanishi K, Okayama A, Yoshimasa Y. The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: the Suita Study. Hypertens Res. 2010;33:1238-1243. https://doi.org/10.1038/hr.2010.174
  39. Seok YM, Cho HJ, Cha BY, Woo JT, Kim IK. Honokiol attenuates vascular contraction through the inhibition of the RhoA/Rhokinase signalling pathway in rat aortic rings. J Pharm Pharmacol. 2011;63:1244-1251. https://doi.org/10.1111/j.2042-7158.2011.01332.x
  40. Kang G, Lee YR, Joo HK, Park MS, Kim CS, Choi S, Jeon BH. Trichostatin A modulates angiotensin II-induced vasoconstriction and blood pressure via inhibition of p66shc activation. Korean J Physiol Pharmacol. 2015;19:467-472. https://doi.org/10.4196/kjpp.2015.19.5.467